Actelion Pharmaceuticals announces availability of PAH Mobile Reference Guide

Actelion Pharmaceuticals US, Inc. is announcing the availability of the Pulmonary Arterial Hypertension (PAH) Mobile Reference Guide, the first multimedia smart phone application that provides information on PAH disease, pathology, diagnosis, and treatment guidelines to healthcare professionals. The complimentary application, which is available on the iPhone®, iPad®, or BlackBerry® for download at www.pahmobile.com or by texting "PAH" to 30305, is accessible from any location.

PAH is a complex disease with diagnosis often delayed for more than two years from onset of symptoms [1]. Dr. Richard Krasuski, staff cardiologist at the Cleveland Clinic stated, "Having this mobile resource of PAH pathology and diagnosis including echocardiogram videos is an important reference tool to help doctors suspect and identify PAH earlier.  I am excited to have this unique tool available for physicians that diagnose, treat and follow PAH patients."

The PAH Mobile Reference Guide provides a detailed source of information, including:

  • PAH Pathology: illustrations and videos
  • Diagnosis: tools and tables detailing signs, symptoms, and tests
  • Treatment: guidelines and algorithms
  • Resources: PAH links, glossary, and references

"PAH is a serious disease that is commonly overlooked or misdiagnosed.  While there has been great progress in developing better treatment options and improving patient care in recent years, there is more work to be done," stated Shal Jacobovitz, president of Actelion Pharmaceuticals US, Inc. "As a leader in PAH, Actelion is pleased to make this PAH Mobile Reference Guide available to physicians.  We are committed to the PAH community and look forward to developing more innovative tools that can improve patient care."  

SOURCE Actelion Ltd

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study focuses on COPD progression in younger populations